{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:44:21Z","timestamp":1787028261850,"version":"build-2736575974"},"reference-count":24,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Healthcare"],"abstract":"<jats:p>Background\/Objectives: Tranexamic acid (TXA) is a synthetic antifibrinolytic agent that inhibits plasminogen activation, thereby reducing bleeding. The aim of this systematic review was to investigate its role in aneurysmal subarachnoid hemorrhage (SAH)\u2014a condition indicated by bleeding between two layers of brain tissue\u2014to stop rebleeding and improve patient outcomes. Methods: We conducted a systematic review and meta-analysis of randomized controlled trials from 1981 to 2024, focusing on the efficacy and safety of TXA in treating aneurysmal SAH (PROSPERO registration: CRD42024504834). Our comprehensive search of the PubMed and Cochrane Library databases identified studies assessing TXA at dosages of 3 to 6 g per day and examining outcomes such as rebleeding incidence, mortality, thromboembolic events, and other adverse effects. Results: From six included studies involving 2990 patients, the meta-analysis showed TXA largely lowered rebleeding risk (OR 0.54 95% CI 0.43\u20130.68; p &lt; 0.00001), yet mortality rates were not largely different between the TXA group (385 out of 1201), and the control group (344 out of 1193) (OR 1.18 95% CI 0.98\u20131.40; p = 0.07). Likewise, there were no large differences in the occurrence of cerebral ischemia and blood clot-related events between the groups. Conclusions: TXA effectively reduces the risk of rebleeding in SAH patients, but does not significantly alter mortality or the incidence of thromboembolic complications. These findings back the careful use of TXA and demonstrate the need for further research to better its clinical use and assess long-term impacts.<\/jats:p>","DOI":"10.3390\/healthcare12232452","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T06:24:44Z","timestamp":1733379884000},"page":"2452","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Effectiveness and Safety of Tranexamic Acid in Treating Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5744-6542","authenticated-orcid":false,"given":"Mohammed O.","family":"Al Zayer","sequence":"first","affiliation":[{"name":"College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam 34212, Eastern Province, Saudi Arabia"},{"name":"Department of Emergency, King Fahad Hospital of the University, Al-Khobar 34445, Eastern Province, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3471-9959","authenticated-orcid":false,"given":"Fatima M.","family":"Al Johani","sequence":"additional","affiliation":[{"name":"Department of Emergency, King Salman Bin Abdulaziz Medical City, Al-Madinah 42319, Al-Madinah Province, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahad A.","family":"Al ghamdi","sequence":"additional","affiliation":[{"name":"College of Pharmacy, King Abdulaziz University, Jeddah 21589, Makkah Province, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5871-7219","authenticated-orcid":false,"given":"Mohammed D.","family":"Al Hejaili","sequence":"additional","affiliation":[{"name":"College of Medicine, Taibah University, Al-Madinah 42353, Al-Madinah Province, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima H.","family":"Al Mukhtar","sequence":"additional","affiliation":[{"name":"College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam 34212, Eastern Province, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9608-7005","authenticated-orcid":false,"given":"Arwa M.","family":"Al Ariany","sequence":"additional","affiliation":[{"name":"College of Medicine, Jeddah University, Jeddah 23218, Makkah Province, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bashar H.","family":"Al Anazi","sequence":"additional","affiliation":[{"name":"Department of Emergency, Prince Sultan Military Medical City, Riyadh 12233, Al-Riyadh Province, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1433-9044","authenticated-orcid":false,"given":"Khalid A.","family":"Al Mutairi","sequence":"additional","affiliation":[{"name":"College of Medicine, Shaqra University, Shaqra 15526, Al-Riyadh Province, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2053-9049","authenticated-orcid":false,"given":"Rammaz H.","family":"Khoja","sequence":"additional","affiliation":[{"name":"College of Medicine, Taibah University, Al-Madinah 42353, Al-Madinah Province, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haidar F.","family":"Al Amer","sequence":"additional","affiliation":[{"name":"Department of Emergency, King Fahad Hospital of the University, Al-Khobar 34445, Eastern Province, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5819-5575","authenticated-orcid":false,"given":"Adel A.","family":"Zeidan","sequence":"additional","affiliation":[{"name":"College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam 34212, Eastern Province, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dunya","family":"Al Faraj","sequence":"additional","affiliation":[{"name":"Department of Emergency, King Fahad Hospital of the University, Al-Khobar 34445, Eastern Province, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1136\/jnnp.2007.117655","article-title":"Incidence of subarachnoid haemorrhage: A systematic review with emphasis on region, age, gender and time trends","volume":"78","author":"Linn","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.emc.2016.06.011","article-title":"Subarachnoid Hemorrhage","volume":"34","author":"Abraham","year":"2016","journal-title":"Emerg. Med. Clin. N. Am."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/ANA.0000000000000130","article-title":"Aneurysmal subarachnoid hemorrhage","volume":"27","year":"2015","journal-title":"J. Neurosurg. Anesthesiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2176\/jns-nmc.2023-0090","article-title":"Incidence and Outcomes of Aneurysmal Subarachnoid Hemorrhage: A Multicenter Retrospective Registry-based Descriptive Trial in Kobe City","volume":"63","author":"Ohta","year":"2023","journal-title":"Neurol. Med. Chir."},{"key":"ref_5","first-page":"519","article-title":"Cognitive and functional outcome after aneurysmal subarachnoid hemorrhage","volume":"41","author":"Macdonald","year":"2010","journal-title":"Stroke"},{"key":"ref_6","first-page":"314","article-title":"2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid Hemorrhage: A Guideline From the American Heart Association\/American Stroke Association","volume":"54","author":"Hoh","year":"2023","journal-title":"Stroke"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1038\/s41467-024-46015-2","article-title":"Diagnosis and management of subarachnoid haemorrhage","volume":"15","author":"Thilak","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.thromres.2014.11.012","article-title":"Tranexamic acid--an old drug still going strong and making a revival","volume":"135","author":"Tengborn","year":"2015","journal-title":"Thromb. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"156","DOI":"10.25259\/SNI_242_2021","article-title":"Commentary on Post, et al. Ultra-early tranexamic acid after subarachnoid hemorrhage: A randomized controlled trial. Lancet 2021","volume":"12","author":"Lo","year":"2021","journal-title":"Surg. Neurol. Int."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0140-6736(20)32518-6","article-title":"Ultra-early tranexamic acid after subarachnoid haemorrhage (ULTRA): A randomised controlled trial","volume":"397","author":"Post","year":"2021","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Shi, M., Yang, C., Chen, Z.-H., Xiao, L.-F., and Zhao, W.-Y. (2022). Efficacy and Safety of Tranexamic Acid in Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Front. Surg., 8.","DOI":"10.3389\/fsurg.2021.790149"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1227\/00006123-198102000-00004","article-title":"Antifibrinolysis with Tranexamic Acid in Aneurysmal Subarachnoid Hemorrhage: A Consecutive Controlled Clinical Trial","volume":"8","author":"Fodstad","year":"1983","journal-title":"Neurosurgery"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/BF01728877","article-title":"Antifibrinolytic Treatment in Subarachnoid Hemorrhage: Present State","volume":"63","author":"Fodstad","year":"1982","journal-title":"Acta Neurochir."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1212\/WNL.54.1.77","article-title":"Antifibrinolytic treatment in subarachnoid hemorrhage: A randomized placebo-controlled trial STAR Study Group","volume":"54","author":"Roos","year":"2000","journal-title":"Neurology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3171\/jns.2002.97.4.0771","article-title":"Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: A prospective randomized study","volume":"97","author":"Hillman","year":"2002","journal-title":"J. Neurosurg."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1212\/WNL.0000000000201160","article-title":"Tranexamic Acid After Aneurysmal Subarachnoid Hemorrhage: Post Hoc Analysis of the ULTRA Trial","volume":"99","author":"Tjerkstra","year":"2022","journal-title":"Neurology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3390\/pathophysiology30030032","article-title":"Pathophysiology, Management, and Therapeutics in Subarachnoid Hemorrhage and Delayed Cerebral Ischemia: An Overview","volume":"30","author":"Sanicola","year":"2023","journal-title":"Pathophysiology"},{"key":"ref_18","unstructured":"Biller, J., Rabinstein, A.A., and Goddeau, R.P. (2023). Nonaneurysmal Subarachnoid Hemorrhage, UpToDate Inc.. Available online: https:\/\/www.uptodate.com\/contents\/nonaneurysmal-subarachnoid-hemorrhage?search=Nonaneurysmal%20subarachnoid%20hemorrhage&source=search_result&selectedTitle=1%7E8&usage_type=default&display_rank=1."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/trf.16976","article-title":"Tranexamic acid: Beyond antifibrinolysis","volume":"62","author":"Prudovsky","year":"2022","journal-title":"Transfusion"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1161\/STR.0b013e3182587839","article-title":"Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association\/American Stroke Association","volume":"43","author":"Connolly","year":"2012","journal-title":"Stroke"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.emc.2020.09.005","article-title":"Diagnosis and Initial Emergency Department Management of Subarachnoid Hemorrhage","volume":"39","author":"Dubosh","year":"2021","journal-title":"Emerg. Med. Clin. N. Am."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.wneu.2021.11.096","article-title":"Therapeutic Approaches for Cerebrovascular Dysfunction After Aneurysmal Subarachnoid Hemorrhage: An Update and Future Perspectives","volume":"159","author":"Torregrossa","year":"2022","journal-title":"World Neurosurg."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1016\/j.mayocp.2021.01.005","article-title":"Diagnosis and Treatment of Unruptured Intracranial Aneurysms and Aneurysmal Subarachnoid Hemorrhage","volume":"96","author":"Tawk","year":"2021","journal-title":"Mayo Clin. Proc."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"}],"container-title":["Healthcare"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9032\/12\/23\/2452\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:47:35Z","timestamp":1760114855000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9032\/12\/23\/2452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,5]]},"references-count":24,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["healthcare12232452"],"URL":"https:\/\/doi.org\/10.3390\/healthcare12232452","relation":{},"ISSN":["2227-9032"],"issn-type":[{"value":"2227-9032","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,5]]}}}